SCHEMBL8499743

SCHEMBL8499743

O=C(O)c1cccc2ncc(-c3cccc(F)c3)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 4/20 0.49
DCLRE1B Q9H816 1/20 0.48
DHODH Q02127 4/20 0.47
KMO O15229 2/20 0.46
EGLN1 Q9GZT9 1/20 0.44
SLC22A12 Q96S37 1/20 0.44
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
GRIN2B Q13224 2/20 0.44
CHEK2 O96017 2/20 0.43
AXL P30530 1/20 0.43
PLK4 O00444 1/20 0.42
AURKA O14965 1/20 0.42
DAPK3 O43293 1/20 0.42
CDK1 P06493 1/20 0.42
PIM1 P11309 1/20 0.42
CDK2 P24941 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
MAPK9 P45984 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8503296 0.88 MAP4K4 (0.47) MAP4K4DCLRE1BDHODHKMOCHEK2
SCHEMBL8912395 0.88 DHODH (0.49) MAP4K4DHODHAXL
SCHEMBL8889861 0.84 MAP4K4 (0.45) MAP4K4EGLN1PDGFRBPDGFRAGRIN2B
SCHEMBL8499635 0.84 AXL (0.49) MAP4K4PDGFRBPDGFRAGRIN2BAXL
SCHEMBL24840523 0.83 DHODH (0.44) DHODH
SCHEMBL31502687 0.83 DHODH (0.44) DHODH
SCHEMBL8503263 0.81 MAP4K4 (0.50) MAP4K4EGLN1PDGFRBPDGFRAGRIN2B
SCHEMBL8887276 0.80 CHEK2 (0.53) MAP4K4SLC22A12CHEK2AXL
SCHEMBL8887805 0.79 CAMKK2 (0.56) MAP4K4DCLRE1BGRIN2BCHEK2AXL
SCHEMBL8502976 0.78 AKR1C3 (0.44) MAP4K4KMOEGLN1SLC22A12PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US claimed
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed